Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 10 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
A Phase 1 Study of SHR-1905, a Long-Acting Anti-Tslp Monoclonal Antibody, in Healthy Subjects and Patients with Asthma
Qian Chen, Chen Yu,Yang Zou, Lika Ye, Jun Yang, Zhi Xiang, Zhihua Shi,Min Zhang, Jianlong Wu, Xin Li, Yingqun Zhu,Lihong Wang,Nan Xu, Xing Gao, Hongda Lin, Meng Fu, Kai Sheng, Jinrui Wang, Huize Han, Xiaopeng Wang
Airway pharmacology and treatment (2024)
Cited0Views0Bibtex
0
0
Screening Analysis of Predictive Markers for Cytokine Release Syndrome Risk in CAR-T Cell Therapy
Jiayu Xu,Chengkui Zhao,Zhenyu Wei, Weixin Xie, Qi Cheng,Min Zhang, Shuangze Han, Liqing Kang,Nan Xu,Lei Yu,Weixing Feng
CURRENT BIOINFORMATICS (2024)
Cited0Views0Bibtex
0
0
Anti-CD19 CAR T-cell Consolidation Therapy Combined with CD19+feeding T Cells and TKI for Ph Plus Acute Lymphoblastic Leukemia
Li-Yun Chen, Wen-Jie Gong, Ming-Hao Li, Hai-Xia Zhou, Ming-Zhu Xu, Chong-Sheng Qian, Li-Qing Kang,Nan Xu, Zhou Yu, Man Qiao, Tong-Tong Zhang,Ling Zhang, Zheng-Long Tian, Ai-Ning Sun,Lei Yu,De-Pei Wu, Sheng-Li Xue
BLOOD ADVANCESno. 17 (2023): 4913-4925
Cited0Views0Bibtex
0
0
CD38-Directed CAR-T Cell Therapy: A Novel Immunotherapy Strategy for Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Xiaowen Tang,Depei Wu, Qingya Cui, Chongsheng Qian,Nan Xu, Liqing Kang, Haiping Dai, Baoquan Song, Wei Cui,Jia Yin, Zheng Li,Lei Yu
Bloodno. Supplement 1 (2020): 34-34
Cited0Views0Bibtex
0
0
Author Statistics

#Papers: 9

#Citation: 36

H-Index: 2

G-Index: 2

Sociability: 4

Diversity: 1

Activity: 2

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn